Acoustically Detonated Microbubbles Coupled with Low Frequency Insonation: Multiparameter Evaluation of Low Energy Mechanical Ablation.
Journal
Bioconjugate chemistry
ISSN: 1520-4812
Titre abrégé: Bioconjug Chem
Pays: United States
ID NLM: 9010319
Informations de publication
Date de publication:
15 06 2022
15 06 2022
Historique:
pubmed:
20
7
2021
medline:
18
6
2022
entrez:
19
7
2021
Statut:
ppublish
Résumé
Noninvasive ultrasound surgery can be achieved using focused ultrasound to locally affect the targeted site without damaging intervening tissues. Mechanical ablation and histotripsy use short and intense acoustic pulses to destroy the tissue via a purely mechanical effect. Here, we show that coupled with low-frequency excitation, targeted microbubbles can serve as mechanical therapeutic warheads that trigger potent mechanical effects in tumors using focused ultrasound. Upon low frequency excitation (250 kHz and below), high amplitude microbubble oscillations occur at substantially lower pressures as compared to higher MHz ultrasonic frequencies. For example, inertial cavitation was initiated at a pressure of 75 kPa for a center frequency of 80 kHz. Low frequency insonation of targeted microbubbles was then used to achieve low energy tumor cell fractionation at pressures below a mechanical index of 1.9, and in accordance with the Food and Drug Administration guidelines. We demonstrate these capabilities in vitro and in vivo. In cell cultures, cell viability was reduced to 16% at a peak negative pressure of 800 kPa at the 250 kHz frequency (mechanical index of 1.6) and to 10% at a peak negative pressure of 250 kPa at a frequency of 80 kHz (mechanical index of 0.9). Following an intratumoral injection of targeted microbubbles into tumor-bearing mice, and coupled with low frequency ultrasound application, significant tumor debulking and cancer cell death was observed. Our findings suggest that reducing the center frequency enhances microbubble-mediated mechanical ablation; thus, this technology provides a unique theranostic platform for safe low energy tumor fractionation, while reducing off-target effects.
Identifiants
pubmed: 34280311
doi: 10.1021/acs.bioconjchem.1c00203
pmc: PMC9204695
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1069-1079Références
Ann Oncol. 2018 Nov 1;29(11):2163-2174
pubmed: 30295695
J Ultrasound Med. 2008 Apr;27(4):611-32; quiz 633-6
pubmed: 18359911
Ultrasound Med Biol. 2016 Jul;42(7):1512-30
pubmed: 27090861
Ultrasound Med Biol. 1998 Feb;24(2):275-83
pubmed: 9550186
Anatol J Cardiol. 2015 Apr;15(4):334-6
pubmed: 25880292
Eur J Surg Oncol. 2010 Dec;36(12):1149-55
pubmed: 20889281
Clin Exp Metastasis. 2005;22(1):47-59
pubmed: 16132578
Sci Rep. 2018 Nov 5;8(1):16347
pubmed: 30397280
J Med Imaging Radiat Oncol. 2013 Aug;57(4):391-9
pubmed: 23870333
JAMA Neurol. 2018 Feb 1;75(2):246-254
pubmed: 29228074
Sci Rep. 2021 Jan 13;11(1):927
pubmed: 33441763
Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:6064-6067
pubmed: 30441719
Radiology. 2020 Jul;296(1):227-235
pubmed: 32343213
Int J Hyperthermia. 2015 Mar;31(2):145-62
pubmed: 25707817
J Biomed Opt. 2001 Apr;6(2):141-50
pubmed: 11375723
Rofo. 2017 Sep;189(9):828-843
pubmed: 28511267
Clin Cancer Res. 2017 Aug 15;23(16):4556-4568
pubmed: 28468947
Int J Hyperthermia. 2019 Oct;36(2):37-45
pubmed: 31537158
Int J Nanomedicine. 2012;7:895-904
pubmed: 22393289
World J Hepatol. 2016 Jan 28;8(3):191-9
pubmed: 26839642
Abdom Radiol (NY). 2018 Apr;43(4):762-772
pubmed: 29508011
Curr Protoc Immunol. 2001 May;Chapter 20:Unit 20.2
pubmed: 18432775
Acta Inform Med. 2011 Sep;19(3):168-71
pubmed: 23408755
Ultrasound Med Biol. 2000 Jul;26(6):1009-19
pubmed: 10996701
Ultrason Sonochem. 2020 Oct;67:105096
pubmed: 32278246
J Neurosurg. 2013 Nov;119(5):1208-20
pubmed: 24010975
J Neurosci Methods. 2014 Sep 30;235:92-100
pubmed: 24970578
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
J Neurosurg. 2011 Jun;114(6):1654-61
pubmed: 21214331
J Control Release. 2015 Apr 28;204:60-9
pubmed: 25724272
Neurosurg Focus. 2018 Feb;44(2):E11
pubmed: 29385926
Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):655-60
pubmed: 23232639
Nat Rev Cancer. 2005 Apr;5(4):321-7
pubmed: 15776004
Expert Opin Drug Deliv. 2017 Sep;14(9):1031-1043
pubmed: 27892760
PLoS One. 2012;7(7):e41632
pubmed: 22911830
J Funct Biomater. 2017 Jun 14;8(2):
pubmed: 28613248
Int J Hyperthermia. 2019;36(1):29-35
pubmed: 30845851
Sci Rep. 2017 Oct 20;7(1):13662
pubmed: 29057881
Ultrasound Med Biol. 2010 May;36(5):840-52
pubmed: 20420973
EBioMedicine. 2019 Dec;50:433-441
pubmed: 31810818
Br J Cancer. 2007 Aug 6;97(3):315-21
pubmed: 17622246
Phys Med Biol. 2013 Jan 7;58(1):127-44
pubmed: 23221109
Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12674-12685
pubmed: 32430322
Acta Neurochir (Wien). 2019 Jan;161(1):99-107
pubmed: 30465276
Theranostics. 2018 Jun 7;8(13):3611-3628
pubmed: 30026870
Oncotarget. 2015 Aug 21;6(24):20241-51
pubmed: 26036312
J Immunother Cancer. 2020 Jan;8(1):
pubmed: 31940590
J Clin Med. 2020 Feb 07;9(2):
pubmed: 32046072
Biomaterials. 2015 Jul;56:104-13
pubmed: 25934284
IEEE Trans Ultrason Ferroelectr Freq Control. 2003 Oct;50(10):1296-304
pubmed: 14609069
Br J Dermatol. 2019 Apr;180(4):740-748
pubmed: 30447074
Theranostics. 2013 Oct 20;3(11):851-64
pubmed: 24312155
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8161-6
pubmed: 24843132
Nat Rev Neurol. 2021 Jan;17(1):7-22
pubmed: 33106619
Ultrasound Med Biol. 2007 Jul;33(7):1140-8
pubmed: 17478030
Sci Rep. 2016 Sep 15;6:33264
pubmed: 27630037
IEEE Trans Ultrason Ferroelectr Freq Control. 2021 May;68(5):1496-1510
pubmed: 33156788
Liver Int. 2019 Oct;39(10):1975-1985
pubmed: 31276296